Search Results - "KORANTZIS, IPPOKRATIS"

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS) by Kotoula, Vassiliki, Krikelis, Dimitrios, Karavasilis, Vasilios, Koletsa, Triantafillia, Eleftheraki, Anastasia G, Televantou, Despina, Christodoulou, Christos, Dimoudis, Stefanos, Korantzis, Ippokratis, Pectasides, Dimitrios, Syrigos, Konstantinos N, Kosmidis, Paris A, Fountzilas, George

“…BRCA1 (B), ERCC1 (E), RRM1 (R) and TYMS (T) mRNA expression has been extensively studied with respect to NSCLC patient outcome upon various chemotherapy…”
Get full text

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study by Papadimitriou, Christos A, Papakostas, Pavlos, Karina, Maria, Malettou, Lia, Dimopoulos, Meletios A, Pentheroudakis, George, Samantas, Epaminontas, Bamias, Aristotelis, Miliaras, Dimosthenis, Basdanis, George, Xiros, Nikolaos, Klouvas, George, Bafaloukos, Dimitrios, Kafiri, Georgia, Papaspirou, Irene, Pectasides, Dimitrios, Karanikiotis, Charisios, Economopoulos, Theofanis, Efstratiou, Ioannis, Korantzis, Ippokratis, Pisanidis, Nikolaos, Makatsoris, Thomas, Matsiakou, Fotini, Aravantinos, Gerasimos, Kalofonos, Haralabos P, Fountzilas, George

“…Colon cancer is a public health problem worldwide. Adjuvant chemotherapy after surgical resection for stage III colon cancer has been shown to improve both…”
Get full text

Delayed malignant melanoma recurrence simulating primary ovarian cancer: case report by Boutis, Anastasios, Valeri, Rosalia, Korantzis, Ippokratis, Valoukas, Dimitrios, Andronikidis, Ioannis, Andreadis, Charalambos

“…Metastatic involvement of the ovary from malignant melanoma is uncommon and presents a diagnostic challenge. Most cases are associated with disseminated…”
Get full text

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer by Ahn, Myung-Ju, Cho, Byoung Chul, Felip, Enriqueta, Korantzis, Ippokratis, Ohashi, Kadoaki, Majem, Margarita, Juan-Vidal, Oscar, Handzhiev, Sabin, Izumi, Hiroki, Lee, Jong-Seok, Dziadziuszko, Rafal, Wolf, Jürgen, Blackhall, Fiona, Reck, Martin, Bustamante Alvarez, Jean, Hummel, Horst-Dieter, Dingemans, Anne-Marie C., Sands, Jacob, Akamatsu, Hiroaki, Owonikoko, Taofeek K., Ramalingam, Suresh S., Borghaei, Hossein, Johnson, Melissa L., Huang, Shuang, Mukherjee, Sujoy, Minocha, Mukul, Jiang, Tony, Martinez, Pablo, Anderson, Erik S., Paz-Ares, Luis

“…AbstractBackgroundTarlatamab, a bispecific T-cell engager immunotherapy targeting delta-like ligand 3 and CD3, showed promising antitumor activity in a phase 1…”
Get full text

Two Randomized Controlled Trials of Romiplostim for Chemotherapy-Induced Thrombocytopenia in Patients with Solid Tumors by Al-Samkari, Hanny, Geredeli, Caglayan, Arslan, Cagatay, Korantzis, Ippokratis, Dogu, Gamze Gokoz, Nechaeva, Marina, Fernandez, Mercedes Salgado, Astorga, Beatriz Gonzalez, Yordanov, Valeriy, Ciuleanu, Tudor-eliade, Bowers, Charles, Armas, Armando, Scotte, Florian, Camargo, Johnny, Muñoz, César, Bunn, Paul, Kuter, David J., Soff, Gerald A.

Get full text

Clinical Outcomes Beyond 1L EGFR -TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL' by Mountzios, Giannis, Koumarianou, Anna, Linardou, Helena, Boutis, Anastasios, Mavroudis, Dimitrios, Samantas, Epaminondas, Korantzis, Ippokratis, Athanasiadis, Elias, Fergadis, Evangelos G, Lampaki, Sofia, Georgoulias, Vassilis, Baka, Sofia, Karamouzis, Michalis V, Boukovinas, Ioannis, Andreadis, Charalampos, Rapti, Aggeliki, Koulouris, Nikolaos, Pentheroudakis, George, Froudarakis, Marios E, Somarakis, Alvertos, Anastasopoulou, Eleftheria, Karadimou, Alexandra, Papageorgiou, Foteini, Paparepa, Zoe, Nikolaou, Aristeidis, Papista, Christina, Syrigos, Konstantinos N

“…Real-world data on the EGFR mutational profile upon progression after first/second-generation EGFR-TKI treatment in patients with advanced non-small-cell lung…”
Get more information

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem by Ziogas, Dimitrios C, Papadatos-Pastos, Dionysios, Thillai, Kiruthikah, Korantzis, Ippokratis, Chowdhury, Ruhe, Suddle, Abid, O’Grady, John, Al-Khadimi, Gillian, Allen, Natalie, Heaton, Nigel, Ross, Paul J, Sarker, Debashis

“…OBJECTIVESorafenib is the standard of care for patients with advanced hepatocellular carcinoma (HCC), but data on its use in the elderly are inconclusive…”
Get full text

Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment by Thillai, Kiruthikah, Repana, Dimitra, Korantzis, Ippokratis, Prachalias, Andreas, Kane, Pauline, Ross, Paul J.

“…Abstract only 637 Background: In patients (pts) with liver-limited metastatic colorectal cancer (mCRC), surgical resection or radiofrequency ablation (RFA) can…”
Get full text

Use of proteins as biomarkers and their role in carcinogenesis by Zarogoulidis, Paul, Tsakiridis, Kosmas, Karapantzou, Chrisanthi, Lampaki, Sofia, Kioumis, Ioannis, Pitsiou, Georgia, Papaiwannou, Antonis, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Kesisis, George, Karapantzos, Ilias, Chlapoutakis, Serafeim, Korantzis, Ippokratis, Mpakas, Andreas, Karavasilis, Vasilis, Mpoukovinas, Ioannis, Li, Qiang, Zarogoulidis, Konstantinos

“…Improved diagnostic methods and medical therapies are necessary for early detection and treatment and an improved prognosis. It is thus vital to both examine…”
Get full text

Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC) by Ziogas, Dimitris, Thillai, Kiruthikah, Papadatos-Pastos, Dionysios, Chowdhury, Mahfuja Hussain Ruhe, Korantzis, Ippokratis, Manickavasagar, Thubeena, Suddle, Abid, O'Grady, John, Heaton, Nigel, Ross, Paul J., Sarker, Debashis

“…Abstract only…”
Get full text

Efficacy of sorafenib in patients with oligometastatic hepatoceulluar carcinoma (HCC) by Thillai, Kiruthikah, Ziogas, Dimitrios, Papadatos-Pastos, Dionysios, Korantzis, Ippokratis, Chowdhury, Mahfuja Hussain Ruhe, Manickavasagar, Thubeena, Suddle, Abid, O'Grady, John, Heaton, Nigel, Ross, Paul J., Sarker, Debashis

“…Abstract only…”
Get full text

Efficacy of sorafenib in patients with oligometastatic hepatoceulluar carcinoma (HCC) by Thillai, Kiruthikah, Ziogas, Dimitrios, Korantzis, Ippokratis, Chowdhury, MH Ruhe, Papadatos-Pastos, Dionysios, Suddle, Abid, O'Grady, John, Heaton, Nigel, Ross, Paul J., Sarker, Debashis

“…Abstract only 389 Background: HCC is the second leading cause of cancer related mortality worldwide. Standard treatment for advanced disease is sorafenib,…”
Get full text

Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC) by Ziogas, Dimitrios, Thillai, Kiruthikah, Korantzis, Ippokratis, Chowdhury, MH Ruhe, Papadatos-Pastos, Dionysios, Suddle, Abid, O'Grady, John, Heaton, Nigel, Ross, Paul J., Sarker, Debashis

“…Abstract only 435 Background: HCC is the third commonest malignancy worldwide, with the highest incidence rates in patients over 75 years of age. Although…”
Get full text

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry by Mountzios, Giannis, Planchard, David, Metro, Giulio, Tsiouda, Dora, Prelaj, Arsela, Lampaki, Sofia, Shalata, Walid, Riudavets, Mariona, Christopoulos, Petros, Girard, Nicolas, Albarrán-Artahona, Víctor, Garcia Campelo, Rosario, Samitas, Konstantinos, Banna, Giuseppe Luigi, Boukovinas, Ioannis, Agbarya, Abed, Koumarianou, Anna, Perdikouri, Eleni-Isidora, Kosmidis, Paris, Linardou, Helena, Mauri, David, Mavroudis, Dimitrios, Athanasiadis, Ilias, Kalofonos, Haralambos, Xenidis, Nikolaos, Korantzis, Ippokratis, Ardavanis, Alexandros, Rallis, Grigorios, Bottiglieri, Achille, Efthymiadis, Konstantinos, Oikonomopoulos, Georgios, Kokkalis, Alexandros, Saloustros, Emmanouil, Tsoukalas, Nikolaos, Bartzi, Dimitra, Economopoulou, Panagiota, Psyrri, Amanda, Reck, Martin, Lo Russo, Giuseppe

“…Real-world evidence regarding molecular epidemiology and management patterns of patients with EGFR exon-20 mutated, advanced NSCLC outside the context of…”
Get full text

Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment by Thillai, Kiruthikah, MBBS MRCP Bsc, Repana, Dimitra, MBBS, Korantzis, Ippokratis, MBBS, Kane, Pauline, MBBS MRCP FRCR, Prachalias, Andreas, MBBS, MD, Ross, Paul, MBBS MRCP PhD

“…Abstract In patients with liver-limited metastatic colorectal cancer, hepatic resection can offer a significant survival benefit over systemic therapy alone…”
Get full text

Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece by Papaxoinis, George, Athanasiadis, Athanasios, Sgouros, Joseph, Visvikis, Anastastios, Drizou, Maria, Kontopodis, Emmanouil, Koumarianou, Anna, Stojanovska, Suzana, Aravantinos, Gerasimos, Korantzis, Ippokratis, Ioannou, Alexandros, Varthalitis, Ioannis, Doufexis, Dimitrios, Nikolaou, Michail, Lypas, Georgios, Bompolaki, Iliada, Christopoulou, Athina, Liontos, Michael, Tsoukalas, Nikolaos, Mauri, Davide, Xenidis, Nikolaos, Katsaounis, Panagiotis, Oikonomopoulos, Georgios, Boukovinas, Ioannis

“…Background. During the last decade, significant improvement was made in systemic therapy of pancreatic adenocarcinoma (PAC). The impact of this progress in…”
Get full text

Expression of Angiogenic Markers in the Peripheral Blood of Patients with Advanced Breast Cancer Treated with Weekly Docetaxel by KORANTZIS, Ippokratis, KALOGERAS, Konstantine T, LINARDOU, Helena, PECTASIDES, Dimitrios, FOUNTZILAS, George, PAPAXOINIS, George, KOTOULA, Vassiliki, KOUTRAS, Angelos, SOUPOS, Nikolaos, PAPAKOSTAS, Pavlos, DIONYSOPOULOS, Dimitrios, SAMANTAS, Epaminontas, CHRISTODOULOU, Christos

“…Metronomic chemotherapy targets the inhibition of tumor growth primarily through antiangiogenic mechanisms. The aim of the present study was to investigate the…”
Get full text

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study by PECTASIDES, Dimitrios, PAPAXOINIS, George, KOSMIDIS, Paris, SKARLOS, Dimosthenis, BOURNAKIS, Evangelos, BAFALOUKOS, Dimitrios, KALOFONOS, Haralabos P, KALOGERAS, Konstantine T, FOUNTZILAS, George, KOTOULA, Vassiliki, FOUNTZILAS, Helen, KORANTZIS, Ippokratis, KOUTRAS, Angelos, DIMOPOULOS, Athanasios M, PAPAKOSTAS, Pavlos, ARAVANTINOS, Gerasimos, VARTHALITIS, Ioannis

“…It is well known that low-dose metronomic chemotherapy has antiangiogenic activity. The aim of the present trial was to investigate the antiangiogenic…”
Get full text

Expression of DNA repair and replication genes in non-small cell lung cancer by Kotoula, Vassiliki, Krikelis, Dimitrios, Karavasilis, Vasilios, Koletsa, Triantafillia, Eleftheraki, Anastasia G, Televantou, Despina, Christodoulou, Christos, Dimoudis, Stefanos, Korantzis, Ippokratis, Pectasides, Dimitrios, Syrigos, Konstantinos N, Kosmidis, Paris A, Fountzilas, George

“…BRCA1 (B), ERCC1 (E), RRM1 (R) and TYMS (T) mRNA expression has been extensively studied with respect to NSCLC patient outcome upon various chemotherapy…”
Get full text

Prognostic Significance of Low HER2 Expression in Patients With Metastatic Hormone Receptor-positive Breast Cancer Treated With First Line CDK4/6 Inhibitors: A Greek Multicenter Real-world Data Analysis by DOUGANIOTIS, GEORGE, KESISIS, GEORGE, LALLA, EFTHALIA, KORANTZIS, IPPOKRATIS, BOUKOVINAS, IOANNIS, PAPAZISIS, KONSTANTINOS

“…Background/Aim: Low expression of HER2 has defined a new “HER2-low” subgroup of breast cancer with distinct clinicopathological characteristics and both…”
Get full text